Shaan Gandhi - Profile and Investment Details

Investor Profile

Shaan Gandhi is a Venture Capital, Investor based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as Vigil Neuroscience, Totus Medicines, Dice Therapeutics, Transition Bio, Inc., Incendia Therapeutics, Aro Biotherapeutics, Candel Therapeutics, StrideBio, Inc, Kyverna Therapeutics, Triumvira Immunologics, Mestag Therapeutics, Stratus Therapeutics, Opna Bio, Northpond Ventures, CAMP4 Therapeutics, Triumvira Immunologics, Inc., 1910, Teckro, . Over time, Shaan Gandhi has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Shaan Gandhi is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Biotechnology, Electronic Health Records (EHR), Health and Hospital Services, Digital Health, Medical, Pharmaceuticals may find it worthwhile to explore potential connections with Shaan Gandhi, as their portfolio suggests a familiarity and interest in this area.

Understanding Shaan Gandhi’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.